TET2 and angioimmunoblastic T-cell lymphoma: Due to the frequent involvement of the TET2, IDH2 and DNMT3A genes in AITL subtypes which are associated with cytosine methylation and hydroxymethylation, DNMT inhibitors such as 5-azacytidine have been evaluated in AITL with reported significant and durable responses (137–139).